Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$27,000.00

Bacteriophages for Treatment of Staphylococcal Periprosthetic Joint Infections

FY 2024-25

Summary
Medical device-associated infections, such as periprosthetic joint infections (PJIs), are a leading cause of hospital-acquired infections. Staphylococcus epidermidis is a primary pathogen in these infections, forming biofilms on implanted devices resistant to host immunity and antibiotics. With the rise of antimicrobial resistance (AMR), antibiotics are becoming less effective, highlighting an urgent need for alternative therapies. Phage therapy (PT), which uses viruses that specifically target bacteria, is emerging as a promising solution. Bacteriophages (phages) are viruses found in diverse environments, including human skin. They have been used clinically in the past; however, use declined with the discovery of antibiotics. As AMR rises, PT is being revisited, but its use requires phages specific to each bacterial strain.This study follows three aims to create a collection of S. epidermidis phages for use in PT. 1. Phage-hunting and genome characterization. Phages will be isolated from skin swabs and tested for infectivity against 14 S. epidermidis strains. Phages will be characterized through RFLP analysis, nanopore sequencing, and electron microscopy. Since May 2024, ~30 novel phages have been isolated and characterized.2. Host-range and activity against biofilms. Host-range assays will assess phage specificity, burst size, virulence, and antibiotic synergy. Preliminary tests on 18 phages against 10 S. epidermidis strains show varied host-range. Biofilm infectivity assays will assess efficacy of phages in disrupting bacterial biofilms, preliminary data demonstrates that 5 strains successfully form biofilms.3. PT characterization. We will further evaluate PT potential by assessing phage activity against clinical isolates from patients with persistent PJIs.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
529800
Name
Wood Emily
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Bacteriophages for Treatment of Staphylococcal Periprosthetic Joint Infections
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antibiotic Resistance; Bacterial Infections; Bacteriophages; Biofilms; Medical Implants; Nosocomial Infections; Periprosthetic Joint Infections; Phage Therapy; Staphylococcus Epidermidis; Viruses
Abstract
Medical device-associated infections, such as periprosthetic joint infections (PJIs), are a leading cause of hospital-acquired infections. Staphylococcus epidermidis is a primary pathogen in these infections, forming biofilms on implanted devices resistant to host immunity and antibiotics. With the rise of antimicrobial resistance (AMR), antibiotics are becoming less effective, highlighting an urgent need for alternative therapies. Phage therapy (PT), which uses viruses that specifically target bacteria, is emerging as a promising solution. Bacteriophages (phages) are viruses found in diverse environments, including human skin. They have been used clinically in the past; however, use declined with the discovery of antibiotics. As AMR rises, PT is being revisited, but its use requires phages specific to each bacterial strain.This study follows three aims to create a collection of S. epidermidis phages for use in PT. 1. Phage-hunting and genome characterization. Phages will be isolated from skin swabs and tested for infectivity against 14 S. epidermidis strains. Phages will be characterized through RFLP analysis, nanopore sequencing, and electron microscopy. Since May 2024, ~30 novel phages have been isolated and characterized.2. Host-range and activity against biofilms. Host-range assays will assess phage specificity, burst size, virulence, and antibiotic synergy. Preliminary tests on 18 phages against 10 S. epidermidis strains show varied host-range. Biofilm infectivity assays will assess efficacy of phages in disrupting bacterial biofilms, preliminary data demonstrates that 5 strains successfully form biofilms.3. PT characterization. We will further evaluate PT potential by assessing phage activity against clinical isolates from patients with persistent PJIs.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wood, Emily
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~